CERAMENT G
Infection prevention in open fractures (Inpatient)
Key Facts
About Bonesupport
BONESUPPORT's mission is to address significant unmet needs in bone repair and infection management through its unique CERAMENT bioceramic technology. The company has achieved a successful transition to a commercial organization, with its flagship product, CERAMENT G, securing critical FDA Breakthrough Device designation and favorable reimbursement from CMS in the US. Its strategy centers on lifecycle management, robust clinical evidence generation, and commercial expansion in Europe and the United States to drive adoption in trauma and orthopedic surgery.
View full company profileAbout Bonesupport
BONESUPPORT's mission is to address significant unmet needs in bone repair and infection management through its unique CERAMENT bioceramic technology. The company has achieved a successful transition to a commercial organization, with its flagship product, CERAMENT G, securing critical FDA Breakthrough Device designation and favorable reimbursement from CMS in the US. Its strategy centers on lifecycle management, robust clinical evidence generation, and commercial expansion in Europe and the United States to drive adoption in trauma and orthopedic surgery.
View full company profileAbout Bonesupport Holding AB
Bonesupport's mission is to revolutionize bone regeneration by overcoming the limitations of traditional bone grafts with its innovative CERAMENT® technology. The company has achieved significant milestones, including FDA approvals for CERAMENT G and V, and has transitioned into a revenue-generating commercial entity with a growing direct sales force. Its strategy focuses on expanding clinical indications, deepening market penetration in core geographies, and leveraging its platform for future product iterations to address a multi-billion dollar global market.
View full company profileAbout Bonesupport Holding AB
Bonesupport's mission is to revolutionize bone regeneration by overcoming the limitations of traditional bone grafts with its innovative CERAMENT® technology. The company has achieved significant milestones, including FDA approvals for CERAMENT G and V, and has transitioned into a revenue-generating commercial entity with a growing direct sales force. Its strategy focuses on expanding clinical indications, deepening market penetration in core geographies, and leveraging its platform for future product iterations to address a multi-billion dollar global market.
View full company profile